These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11558453)

  • 1. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 2. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin: a therapeutic review.
    Wimer SM; Schoonover L; Garrison MW
    Clin Ther; 1998; 20(6):1049-70. PubMed ID: 9916602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin.
    Norrby SR
    Expert Opin Pharmacother; 1999 Nov; 1(1):109-19. PubMed ID: 11249554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial activity and action mechanism of ofloxacin].
    Padeĭskaia EN
    Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial effect of levofloxacin].
    Mitrokhin SD
    Antibiot Khimioter; 2003; 48(11):23-30. PubMed ID: 15106308
    [No Abstract]   [Full Text] [Related]  

  • 9. Levofloxacin, a new quinolone antibacterial agent. An introductory overview.
    Hayakawa I; Furuhama K; Takayama S; Osada Y
    Arzneimittelforschung; 1992 Mar; 43(3A):363-4. PubMed ID: 1622431
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of levofloxacin.
    Nightingale CH; Grant EM; Quintiliani R
    Chemotherapy; 2000; 46 Suppl 1():6-14. PubMed ID: 10810208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levofloxacin (Tavanic) in the treatment of corneal ulcers].
    Maĭchuk IuF
    Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.
    Nakamori Y; Miyashita Y; Nakatani I; Nakata K
    Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms.
    Tarai B; Das P; Kumar D
    Indian J Med Microbiol; 2014; 32(3):353-4. PubMed ID: 25008844
    [No Abstract]   [Full Text] [Related]  

  • 17. Levofloxacin elimination during albumin dialysis.
    Bellmann R; Egger P; Pechlaner C; Feistritzer C; Vogel W; Joannidis M; Wiedermann CJ
    Int J Artif Organs; 2003 Apr; 26(4):358-9. PubMed ID: 12757036
    [No Abstract]   [Full Text] [Related]  

  • 18. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
    Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
    Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of murine listeriosis and salmonellosis with levofloxacin.
    Nichterlein T; Bornitz F; Kretschmar M; Hof H
    J Chemother; 1998 Aug; 10(4):313-9. PubMed ID: 9720471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.
    Edlund C; Sjöstedt S; Nord CE
    Scand J Infect Dis; 1997; 29(4):383-6. PubMed ID: 9360254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.